| Identification | Back Directory | [Name]
9,11,15-Trioxa-6-aza-10-phosphatritriacont-24-enoic acid, 10-hydroxy-5,16-dioxo-13-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]-, 2,5-dioxo-1-pyrrolidinyl ester, 10-oxide, (13R,24Z)- | [CAS]
1010188-79-0 | [Synonyms]
(2R)-3-(((2-(5-((2,5-Dioxopyrrolidin-1-yl)oxy)-5-oxopentanamido)ethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl dioleate
9,11,15-Trioxa-6-aza-10-phosphatritriacont-24-enoic acid, 10-hydroxy-5,16-dioxo-13-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]-, 2,5-dioxo-1-pyrrolidinyl ester, 10-oxide, (13R,24Z)- | [Molecular Formula]
C50H87N2O13P | [MOL File]
1010188-79-0.mol | [Molecular Weight]
955.21 |
| Hazard Information | Back Directory | [Uses]
DOPE-NHS is a linker. DOPE-NHS can be used for peptides to be conjugated to exosomes and possibly other membrane-based nanoparticles. DOPE-NHS can be used for drug delivery[1]. | [References]
[1] Cui GH, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immun Ageing. 2019 May 13;16:10. DOI:10.1186/s12979-019-0150-2 |
|
|